Pancreatic Cancer Research

ResearcherShanghai University of Traditional Chinese MedicineActive in the last 2 years

Mingxing Wang

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-7930-9665; OpenAlex author ID A5100658586. Sources: OpenAlex.

Their work

Papers
5
Trials
0
Grants
0
Labs led
0
Collaborators
8
Papers, trials and grants by year

2020: 1 paper · 2021: 1 paper · 2022: 2 papers · 2023: none · 2024: none · 2025: none · 2026: 1 paper

Papers 5

  1. Imbalance in radiographic progression proportion as a potential confounder in evaluating the survival benefit of an adding-on strategy in metastatic pancreatic… Co-author DOI 10.1016/j.jfma.2026.05.090↗
  2. Tumor-mutation burden as a marker for immunotherapy of pancreatic cancer: the case report and literature review. Co-author DOI 10.1097/cad.0000000000001232↗
  3. Conversion therapy, palliative chemotherapy and surgery, which of these is the best treatment for locally advanced and advanced pancreatic cancer? Co-author DOI 10.1097/cad.0000000000001235↗
  4. Conversion Therapy of Unresectable Pancreatic Cancer: A Retrospective Study of the Real World Co-author DOI 10.21203/rs.3.rs-674137/v1↗
  5. Conversion Therapy for Advanced Pancreatic Cancer: The Case Series and Literature Review. Co-author DOI 10.3389/fphar.2020.579239↗

Closest collaborators

The 8 strongest of 8 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Zheling Chen · 4 shared papers, 2020–2022 · strength 0.70
  2. Yahao Li · 1 shared paper, 2026 · strength 0.63
  3. Liu Yang · 2 shared papers, 2021–2022 · strength 0.42
  4. Peng-Fei Zhu · 2 shared papers, 2021–2022 · strength 0.37
  5. Yang Liu · 1 shared paper, 2022 · strength 0.17
  6. Yunyun Xu · 1 shared paper, 2020 · strength 0.11
  7. Jiahong Jiang · 1 shared paper, 2020 · strength 0.11
  8. Dongsheng Huang · 1 shared paper, 2020 · strength 0.11

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.